These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6752290)
1. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells. Morhenn VB; Benike CJ; Charron DJ; Cox A; Mahrle G; Wood GS; Engleman EG J Invest Dermatol; 1982 Nov; 79(5):277-82. PubMed ID: 6752290 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells. Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529 [TBL] [Abstract][Full Text] [Related]
3. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions. Sontheimer RD J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806 [TBL] [Abstract][Full Text] [Related]
4. Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study. Bronstein BR; Murphy GF; Harrist TJ; Ruiter DJ; Mihm MC; Bhan AK J Invest Dermatol; 1983 Jun; 80(6):481-4. PubMed ID: 6343512 [TBL] [Abstract][Full Text] [Related]
5. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. Meunier L; Bohjanen K; Voorhees JJ; Cooper KD J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614 [TBL] [Abstract][Full Text] [Related]
7. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218 [TBL] [Abstract][Full Text] [Related]
9. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells. Czernielewski JM; Schmitt D; Faure MR; Thivolet J Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266 [TBL] [Abstract][Full Text] [Related]
10. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342 [TBL] [Abstract][Full Text] [Related]
11. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function. Ashworth J; Kahan MC; Breathnach SM Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456 [TBL] [Abstract][Full Text] [Related]
12. Class II transplantation antigens in the late human skin tuberculin reaction. Scheynius A; Tjernlund U Scand J Immunol; 1985 Aug; 22(2):227-33. PubMed ID: 2412281 [TBL] [Abstract][Full Text] [Related]
13. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells. Engleman EG; Charron DJ; Benike CJ; Stewart GJ J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944 [TBL] [Abstract][Full Text] [Related]
14. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours. Löning T; Caselitz J; Seifert G; Weber K; Osborn M Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705 [TBL] [Abstract][Full Text] [Related]
15. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells. Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional control of HLA-A,B,C antigen in human placental cytotrophoblast isolated using trophoblast- and HLA-specific monoclonal antibodies and the fluorescence-activated cell sorter. Kawata M; Parnes JR; Herzenberg LA J Exp Med; 1984 Sep; 160(3):633-51. PubMed ID: 6206184 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence microscopic and flow cytometric analysis of bone marrow-derived cells in human epidermis: a search for the human analogue of the murine dendritic Thy-1+ epidermal cell. Cooper KD; Breathnach SM; Caughman SW; Palini AG; Waxdal MJ; Katz SI J Invest Dermatol; 1985 Dec; 85(6):546-52. PubMed ID: 2866216 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity. Ashworth J; Kahan MC; Breathnach SM J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952 [TBL] [Abstract][Full Text] [Related]
19. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells. van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521 [TBL] [Abstract][Full Text] [Related]
20. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. Haftek M; Faure M; Schmitt D; Thivolet J J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]